tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Codexis (CDXS) and Phathom Pharmaceuticals (PHAT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Codexis (CDXSResearch Report) and Phathom Pharmaceuticals (PHATResearch Report) with bullish sentiments.

Codexis (CDXS)

Craig-Hallum analyst Matt Hewitt assigned a Buy rating to Codexis today. The company’s shares closed last Thursday at $2.76.

According to TipRanks.com, Hewitt has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -4.0% and a 43.3% success rate. Hewitt covers the Healthcare sector, focusing on stocks such as Streamline Health Solutions, Champions Oncology, and BioLife Solutions.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Codexis with a $6.00 average price target, which is an 119.0% upside from current levels. In a report issued on January 18, Piper Sandler also maintained a Buy rating on the stock with a $10.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Phathom Pharmaceuticals (PHAT)

Needham analyst Joseph Stringer maintained a Buy rating on Phathom Pharmaceuticals today and set a price target of $26.00. The company’s shares closed last Thursday at $6.66, close to its 52-week low of $5.84.

According to TipRanks.com, Stringer is a 1-star analyst with an average return of -1.6% and a 39.0% success rate. Stringer covers the Healthcare sector, focusing on stocks such as Apellis Pharmaceuticals, Vertex Pharmaceuticals, and Rhythm Pharmaceuticals.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Phathom Pharmaceuticals with a $22.75 average price target, implying a 234.6% upside from current levels. In a report issued on January 25, Craig-Hallum also assigned a Buy rating to the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on CDXS:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles